Brought to you by 
Roche's antibody research boosted by $56.5mm purchase of THP
03 May 2007
Executive Summary
Roche has acquired Therapeutic Human Polyclonals (THP) for $56.5mm in cash and plans to incorporate the antibody research company into the Roche Pharma Center of Excellence for Protein Research.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Roche's antibody research boosted by $56.5mm purchase of THP
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice